6589 台康生技


股價漲跌幅
202220212020
台康生技-25.0%151.0%-6.0%
0050-15.78%3.82%50.48%


現價可能漲跌幅 1合理價(本益比法)一年後目標價報酬率可能漲跌幅 2合理價(ROE法)
80.3 N/A N/A N/A N/A N/A N/A

  • 合理價(本益比法): 從 "一年後目標價" 回推得到
  • 可能漲跌幅 1: "合理價(本益比法)" 和 "現價" 的差距
  • 報酬率: 一年後可能的報酬率
  • 可能漲跌幅 2: "合理價(ROE法)" 和 "現價" 的差距
  • 推估價格僅供參考, Please Do Your Own Research

營業毛利率,營業利益率,稅前淨利率,股東權益報酬率-近10年
202120202019201820172016201520142013
營業毛利率64.4070.0453.4928.0738.6734.407.22-39.78-484.19
營業利益率-3.44-91.99-178.05-133.40-58.77-54.46-153.91-287.84-1231.74
折舊負擔比率9.9614.7421.0110.288.727.9116.5025.9388.89
稅前淨利率-2.43-97.15-180.83-130.34-58.75-44.47-131.20-247.03-1221.73
股東權益報酬率-0.69-55.40-43.67-22.76-14.27-11.18-17.77-21.300.00
資產報酬率-0.34-28.10-26.47-15.70-11.04-10.01-16.15-18.400.00
本業收入比141.4694.7298.49102.17100.00122.12117.04116.54100.95
業外獲益比-41.465.281.51-2.45-0.00-22.12-17.04-16.54-0.95
無形資產佔淨值比0.170.861.231.820.000.000.000.000.00

營業毛利率,營業利益率,稅前淨利率,股東權益報酬率-近20季
22Q121Q421Q321Q221Q120Q420Q320Q220Q119Q419Q319Q219Q118Q418Q318Q218Q1
營業毛利率67.9452.1681.4250.6960.7761.2179.5462.0570.2153.9537.9661.9954.0936.8025.5627.5121.92
營業利益率-9.732.3348.76-43.39-92.62-115.98-15.22-147.47-147.07-176.06-327.37-87.55-183.73-143.48-159.93-100.33-134.32
稅前淨利率3.920.8050.61-39.51-93.85-124.53-17.80-155.66-150.38-181.25-335.78-87.57-180.78-137.30-158.58-95.56-134.64
本業收入比-250.00333.3396.39110.2098.7093.2285.7194.8297.9997.1697.34100.00101.36103.88100.00105.80100.00
業外獲益比350.00-200.003.61-9.521.306.7814.295.182.302.842.660.00-1.36-4.85-1.05-4.350.00

現金流量-近10年 (1.避開自由現金流量近3年都小於0的公司 2.營運現金流量要大於稅後淨利,除非受到應收帳款和存貨影響 3.營運現金流量不應該都是流出)
202120202019201820172016201520142013
營運現金流量(百萬)-30-419-784-466-190-54-146-115-86
自由現金流量(百萬)-1787-647-1268-1302-581-304-214-216-260
稅後淨利(百萬)-43-1042-861-368-175-112-135-133-105


現金流量-近20季
22Q121Q421Q321Q221Q120Q420Q320Q220Q119Q419Q319Q219Q118Q418Q318Q218Q1
營運現金流量(百萬)-40-90400-23-316-6-154-112-148-221-217-95-252-88-111-154-112
自由現金流量(百萬)295-1178-314-64-231577-207-851-167-294-338-238-400-538-303-275-185
稅後淨利(百萬)143332-148-230-295-70-328-348-282-301-131-147-103-95-69-101

成長能力-近10年 (營業利益和稅後淨利成長率要大於營收成長率)
202120202019201820172016201520142013
營收(百萬)16971072476282298253103549
營業利益(百萬)-58-986-848-376-175-138-158-155-106
稅後淨利(百萬)-43-1042-861-368-175-112-135-133-105
EPS(完全稀釋)0.000.00-5.39-2.97-1.70-1.15-1.690.00-2.72
營收成長率(%)58.30125.2168.79-5.3717.79145.6390.74500.00N/A
營業利益成長率(%)N/AN/AN/AN/AN/AN/AN/AN/AN/A
稅後淨利成長率(%)N/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS成長率(%)N/AN/AN/AN/AN/AN/AN/AN/AN/A

成長能力-近20季
22Q121Q421Q321Q221Q120Q420Q320Q220Q119Q419Q319Q219Q118Q418Q318Q218Q1
營收(百萬)362424657372245237392211232156901508175607375
營業利益(百萬)-3510320-162-227-275-60-311-341-274-293-131-149-107-95-73-101
稅後淨利(百萬)143332-148-230-295-70-328-348-282-301-131-147-103-95-69-101
EPS(完全稀釋)0.050.011.36-0.65-1.11-1.53-0.34-1.74-2.06-1.77-1.78-0.87-0.98-0.83-0.80-0.56-0.81
去年同期營收成長率(%)47.7678.9067.6076.305.6051.92335.5640.67186.42108.0050.00105.488.000.000.000.00-
去年同期營業利益成長率(%)84.58103.64633.3347.9133.43-0.3679.52-137.40-128.86-156.07-208.42-79.45-47.520.000.000.00-
去年同期稅後淨利成長率(%)106.09101.02574.2954.8833.91-4.6176.74-150.38-136.73-173.79-216.84-89.86-45.540.000.000.00-
去年同期EPS成長率(%)104.50100.65500.0062.6446.1213.5680.90-100.00-110.20-113.25-122.50-55.36-20.990.000.000.00-
較上季營收成長率(%)-14.62-35.4676.6151.843.38-39.5485.78-9.0548.7273.33-40.0085.198.0025.00-17.81-2.670.00
較上季營業利益成長率(%)-450.00-96.88297.5328.6317.45-358.3380.718.80-24.456.48-123.6612.08-39.25-12.63-30.1427.720.00
較上季稅後淨利成長率(%)366.67-99.10324.3235.6522.03-321.4378.665.75-23.406.31-129.7710.88-42.72-8.42-37.6831.680.00
較上季EPS成長率(%)400.00-99.26309.2341.4427.45-350.0080.4615.53-16.380.56-104.6011.22-18.07-3.75-42.8630.860.00

每月營收變化
年/月月增率(%)去年同期年增率(%)累計營收年增率(%)年/月月增率(%)去年同期年增率(%)累計營收年增率(%)
2022/446.02-5.730.532019/12101.94336.6769.02
2022/315.64-9.7547.692019/1140.1246.6649.26
2022/1~2-70.8277.1577.152019/1010.4611.7449.58
2021/1255.73164.4458.492019/9-12.9431.7154.47
2021/1116.4459.2450.742019/8-0.681.9156.97
2021/1034.9323.7450.022019/7-68.7943.0954.46
2021/9-54.6-70.5352.732019/6521.21403.9256.14
2021/8-56.95220.61111.032019/5-50.85-51.851.92
2021/7255.58472.9399.432019/4-16.1671.5821.08
2021/6-20.5176.5539.792019/3156.68110.448.19
2021/523.25150.5633.522019/1~2-42.76-25.59-25.58
2021/439.7429.7412.672018/12-32.1729.67-5.25
2021/316.25-13.026.062018/116.76-1.61-7.1
2021/1~2-21.1119.5219.522018/1030.2-38.86-7.73
2020/12-6.21-13.85124.52018/920.23-41.8-1.23
2020/11-9.5185.5154.392018/8-21.81-39.916.98
2020/10-67.86187.27162.652018/714.22-27.616.13
2020/9393.88887.59160.342018/6-42.915.0326.89
2020/8-23.0874.0793.092018/575.16100.4530.98
2020/79.57124.9495.352018/42.8210.3516.58
2020/612.8-35.9491.342018/3-34.01-15.0518.29
2020/5-36.17252.73189.452018/1~20.2835.9335.93
2020/4-6.32171.61180.492017/12-15.97-1.921.42
2020/39.87143.08184.092017/11-33.6537.3323.97
2020/1~278.72222.4222.42017/1023.9376.7422.6

稅前淨利較去年同期
(百萬)(百萬)YoY(%)
000
(百萬)(百萬)YoY(%)
000
(百萬)(百萬)YoY(%)
000

EPS較上季
2022Q1(元)2021Q4(元)比率
0.050.014.0

應收帳周轉率和存貨周轉率-近10年
20212020201920182017201620152014
應收帳款周轉率19.547.925.203.972.563.452.713.63
存貨周轉率2.101.982.163.763.257.360.000.00

應收帳周轉率和存貨周轉率-近20季
22Q121Q421Q321Q221Q1
應收帳款周轉率4.096.275.612.412.19
存貨周轉率0.240.520.370.680.47

償債能力-近10年
202120202019201820172016201520142013
負債比0.090.500.460.300.320.110.090.090.19
金融負債(百萬)12771775166720800030
營收淨額(百萬)16971072476282298253103549
利息保障倍數-0.95-35.54-45.47-235.85-4267.27-3041.14-910.14-83.600.00
長期銀行借款占稅後淨利比0.000.000.000.000.000.000.000.000.00

成本指標-近10年
202120202019201820172016201520142013
營收淨額(百萬)16971072476282298253103549
推銷費用(百萬)34272519192122146
管理費用(百萬)224148118927254452618
研發費(百萬)8941562960344199150999341
推銷費用率(%)2.002.525.256.746.388.3021.3625.9366.67
管理費用率(%)13.2013.8124.7932.6224.1621.3443.6948.15200.00
研發費用率(%)52.68145.71201.68121.9966.7859.2996.12172.22455.56

成本指標-近20季
22Q121Q421Q321Q221Q120Q420Q320Q220Q119Q419Q319Q219Q118Q418Q318Q218Q1
營收淨額(百萬)362424657372245237392211232156901508175607375
推銷費用(百萬)10106116967567755554
管理費用(百萬)7452458840413940293030292929252018
研發費(百萬)197148163252330370327395469322291188159101816895
推銷費用率(%)2.762.360.912.962.453.801.533.322.163.857.784.676.176.678.336.855.33
管理費用率(%)20.4412.266.8523.6616.3317.309.9518.9612.5019.2333.3319.3335.8038.6741.6727.4024.00
研發費用率(%)54.4234.9124.8167.74134.69156.1283.42187.20202.16206.41323.33125.33196.30134.67135.0093.15126.67

財務健檢燈號
公司上市滿三年資本額10億以上股本形成中現金增資比率低於50%負債比率低於50%董監持股設質低於10%現金(含約當現金)占股本超過50%過去4季累積正營運現金流量過去4季ROE超過25%過去6個月的營收維持正的年成長率過去4季的EPS年增率是正數
6589-台康生技OOXOOOOXXO
3年30.04億93.79%8.48%8.03%229.98%247百萬0.52%


台康生技熱門網頁

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。